Desq Long
Sign in
SEC FORM 4
—

ADARx Pharmaceuticals, Inc. (ADRX)

Acquisition (code C) of 153,868 shares; price not stated (see filing).

Reporting Persons LAV Biosciences Fund V, L.P. · LAV Fund VI Opportunities, L.P. · LAV Fund VI, L.P. · Transaction Code C

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001231919-26-001406 · filed 2026-09-29 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "ADARx Pharmaceuticals, Inc. (ADRX)." Disclosed 2026-09-29. https://desqlong.com/cards/0001231919-26-001406-4 (retrieved 2026-09-30).